EXPLAINED: Is becton dickinson and company stock underperforming the dow | Rare Historical Photos

With a market cap of $64 billion, Franklin Lakes, New Jersey-based Becton, Dickinson and Company (BDX) is a global medical technology leader. Operating through three key segments: BD Medical; BD Life Sciences; and BD Interventional, the company offers a diverse range of solutions, including advanced catheters, diagnostic assays, and surgical products.

Companies valued at $10 billion or more are considered "large-cap" stocks, and Becton, Dickinson and Company fits this criterion perfectly. With a focus on improving patient care and advancing medical discovery, BDX is pivotal in addressing healthcare challenges worldwide. It specializes in developing, manufacturing, and selling medical devices, laboratory equipment, and diagnostic products for healthcare providers, researchers, and the general public.